We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




HIV Fusion Protein Reduces Membrane Energy Barrier

By Biotechdaily staff writers
Posted on 07 Aug 2007
Researchers studying the interaction between HIV and human T-cells have found that an HIV fusion peptide lowers the energy required for the cell membrane to bend, making it easier for the virus to enter the cell.

The HIV gp120 protein initiates binding of the virus onto the host T-cell. More...
Another protein --gp41--then enables HIV to penetrate the T-cell membrane. Fusion takes place specifically through a short stretch of gp41 called fusion peptide 23 (FP-23). To better understand how FP-23 functions investigators at Carnegie Mellon University (Pittsburgh, PA, USA) used an X-ray diffusion technique to study how this HIV fusion peptide affected the energy of synthetic lipid bilayers that had been designed to mimic normal cell membranes.

Results published in the May 25, 2007, online edition of the Biophysical Journal revealed that the bending modulus of the membrane was greatly reduced upon addition of the HIV fusion peptide FP-23 to lipid bilayers. A smaller bending modulus reduced the free energy barriers required to achieve and pass through the highly curved intermediate states and thereby facilitated fusion and HIV infection. Overall, FP-23 reduced the energy required to penetrate an artificial cell membrane by up to 13-fold, depending on the thickness of that membrane.

"We found that HIV fusion peptide dramatically decreases the amount of energy needed to bend a cell-like membrane,” said first author Dr. Stephanie Tristram-Nagle, associate research professor of biological physics at Carnegie Mellon University. "This helps membranes to curve, a necessary step for HIV to fuse with an immune cell as it infects it. Reducing this energy should help explain in part how HIV infection occurs so readily. Our findings definitely will change how theoreticians think about virus-cell interactions. This same phenomenon could provide a general way that viruses use to infect cells, so it will be exciting to look at other viral systems with our experimental method.”


Related Links:
Carnegie Mellon University

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.